Marvel Biosciences Corp. (TSXV:MRVL)
Canada
· Delayed Price · Currency is CAD 0.0900
+0.0050 (5.88%)
May 9, 2025, 2:34 PM EDT
Marvel Biosciences Market Cap
Marvel Biosciences has a market cap or net worth of CAD 4.03 million as of May 9, 2025. Its market cap has decreased by -27.61% in one year.
Market Cap
4.03M
Enterprise Value
5.68M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 12.71M to 4.03M, a decrease of -68.27%. That is a compound annual growth rate of -25.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 4.03M | -47.04% |
| Dec 31, 2024 | 7.61M | 139.21% |
| Dec 29, 2023 | 3.18M | -36.00% |
| Dec 30, 2022 | 4.97M | -43.47% |
| Dec 30, 2021 | 8.80M | -30.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 1.92B |
| dentalcorp Holdings | 1.73B |
| Sienna Senior Living | 1.59B |
| Trulieve Cannabis | 1.19B |
| Extendicare | 1.18B |
| Cronos Group | 1.06B |
| WELL Health Technologies | 983.80M |
| Curaleaf Holdings | 916.44M |